Advanced search
Start date

Biotransformations of baccharin from green propolis using filamentous fungi and bacteria from the intestinal microbiota

Grant number: 18/03476-0
Support type:Scholarships in Brazil - Master
Effective date (Start): June 01, 2018
Effective date (End): February 29, 2020
Field of knowledge:Physical Sciences and Mathematics - Chemistry - Organic Chemistry
Cooperation agreement: Coordination of Improvement of Higher Education Personnel (CAPES)
Principal researcher:Niege Araçari Jacometti Cardoso Furtado
Grantee:Adriany Dias Fonseca
Home Institution: Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Associated research grant:17/04138-8 - Attainment of chemical, analytical, biological, pharmacological and technological studies to fill the gaps on the development of Brazilian propolis sector, AP.TEM


Green propolis has high commercial and medicinal value and among its constituents is baccharin, one of the major compounds found in Baccharis dracunculifolia, the main botanical source of green propolis. Baccharin is notable for inhibiting the enzyme aldo-keto reductase 1C3, which in the mammary gland converts 4-androstane-3,17-dione into testosterone which can subsequently be converted to 17²-estradiol, in addition to converting estrone to 17²-estradiol . In the prostate this enzyme converts 4-androstene-3,17-dione and 5±-androstane-3,17-dione to testosterone and 5±-dihydrotestosterone, respectively. Therefore, the inhibition of this enzyme is beneficial to prevent the proliferation of tumor cells in two types of highly prevalent neoplasias: breast and prostate cancer. Biotransformation studies with filamentous fungi may provide the same metabolite produced in the human organism and the use of bacteria from the intestinal microbiota in in vitro metabolism studies is important because these microorganisms are able to metabolize drugs and foods after ingestion. In this project, it is proposed to carry out biotransformation studies of baccharin starting with a screening involving two strains of filamentous fungi and three strains of bacteria from the gastrointestinal tract in isolated and mixed cultures. Extracts from the cultures will be obtained and analyzed by TLC and HPLC-DAD. The most promising process will be selected for large-scale development and the major compounds will be isolated and elucidated. There are no biotransformation studies of baccharin and the aim of this study is to obtain information to understand how baccharin could be transformed into human organism, as well as to contribute to obtain new derivatives. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items